Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy.

Hugo PerazzoSandra W CardosoCarolyn YanavichEstevão P NunesMichelle MorataNathalia GorniPaula Simplicio da SilvaClaudia CardosoCristiane AlmeidaPaula Mendes LuzValdilea G VelosoBeatriz Grinsztejn

Published in: Journal of the International AIDS Society (2019)

Integrated strategies for preventing non-communicable diseases in people with HIV mono-infection are necessary to decrease the burden of liver diseases. Clinical Trial Number: NCT02542020.

Keyphrases

antiretroviral therapy
liver fibrosis
hiv infected
hiv positive
human immunodeficiency virus
hiv aids
hiv infected patients
clinical trial
hiv testing
hepatitis c virus
men who have sex with men
high fat diet
open label
insulin resistance
south africa
phase ii
type diabetes
study protocol
metabolic syndrome